Atlas Trials

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

Clinical trial NCT04862585 · COMPLETED

Trial details

NCT number
NCT04862585
Sponsor
Ohio State University Comprehensive Cancer Center
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8
Start date
2021-10-07
Primary completion
2024-06-21
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.